Treatment and costs associated with anemic chronic kidney disease patients

Rafia Sultana Rasu, Tonya Crawford, Harold Manley, Rajesh Balkrishnan

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Objective: The purpose of this paper is to provide an overview of the current therapeutic options afforded to anemic chronic kidney disease (CKD) patients and the costs of these interventions. Methodology: Literature search of articles within Ovid MEDLINE between 1996 and 2007 that pertained to the treatment of anemia in chronic kidney disease patients. Results: Early detection and treatment of anemia associated with CKD has proven to provide positive cognitive and physical effects. Treatment options that increase iron storage and availability within the body and production of erythropoietin can assist in anemic CKD patients in achieving recommended levels of hemoglobin. Acknowledgement of the potential side effects associated with the medications selected to treat anemia can help in avoiding additional injury to the patient and thus reduce healthcare expenditure. A limitation of this review is that the search was performed within a single database. Conclusions: Health care providers can play an active role in detecting anemia early and optimizing available treatment options. Future research on the effects of erythropoiesis-stimulating agents (ESA) on patients before they need dialysis, and a cost analysis between epoetin and darbepoetin alpha, would be beneficial.

Original languageEnglish
Pages (from-to)129-137
Number of pages9
JournalCurrent Medical Research and Opinion
Volume24
Issue number1
DOIs
StatePublished - 1 Jan 2008

Fingerprint

Chronic Renal Insufficiency
Health Care Costs
Anemia
Epoetin Alfa
Hematinics
Therapeutics
Cost of Illness
Health Expenditures
Erythropoietin
MEDLINE
Health Personnel
Dialysis
Hemoglobins
Iron
Databases
Delivery of Health Care
Costs and Cost Analysis
Wounds and Injuries

Keywords

  • Anemia
  • Health care costs
  • Kidney diseases
  • Quality of life

Cite this

Rasu, Rafia Sultana ; Crawford, Tonya ; Manley, Harold ; Balkrishnan, Rajesh. / Treatment and costs associated with anemic chronic kidney disease patients. In: Current Medical Research and Opinion. 2008 ; Vol. 24, No. 1. pp. 129-137.
@article{c786e891b2fa461a856ce55a26efc7a4,
title = "Treatment and costs associated with anemic chronic kidney disease patients",
abstract = "Objective: The purpose of this paper is to provide an overview of the current therapeutic options afforded to anemic chronic kidney disease (CKD) patients and the costs of these interventions. Methodology: Literature search of articles within Ovid MEDLINE between 1996 and 2007 that pertained to the treatment of anemia in chronic kidney disease patients. Results: Early detection and treatment of anemia associated with CKD has proven to provide positive cognitive and physical effects. Treatment options that increase iron storage and availability within the body and production of erythropoietin can assist in anemic CKD patients in achieving recommended levels of hemoglobin. Acknowledgement of the potential side effects associated with the medications selected to treat anemia can help in avoiding additional injury to the patient and thus reduce healthcare expenditure. A limitation of this review is that the search was performed within a single database. Conclusions: Health care providers can play an active role in detecting anemia early and optimizing available treatment options. Future research on the effects of erythropoiesis-stimulating agents (ESA) on patients before they need dialysis, and a cost analysis between epoetin and darbepoetin alpha, would be beneficial.",
keywords = "Anemia, Health care costs, Kidney diseases, Quality of life",
author = "Rasu, {Rafia Sultana} and Tonya Crawford and Harold Manley and Rajesh Balkrishnan",
year = "2008",
month = "1",
day = "1",
doi = "10.1185/030079908X242782",
language = "English",
volume = "24",
pages = "129--137",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

Treatment and costs associated with anemic chronic kidney disease patients. / Rasu, Rafia Sultana; Crawford, Tonya; Manley, Harold; Balkrishnan, Rajesh.

In: Current Medical Research and Opinion, Vol. 24, No. 1, 01.01.2008, p. 129-137.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Treatment and costs associated with anemic chronic kidney disease patients

AU - Rasu, Rafia Sultana

AU - Crawford, Tonya

AU - Manley, Harold

AU - Balkrishnan, Rajesh

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Objective: The purpose of this paper is to provide an overview of the current therapeutic options afforded to anemic chronic kidney disease (CKD) patients and the costs of these interventions. Methodology: Literature search of articles within Ovid MEDLINE between 1996 and 2007 that pertained to the treatment of anemia in chronic kidney disease patients. Results: Early detection and treatment of anemia associated with CKD has proven to provide positive cognitive and physical effects. Treatment options that increase iron storage and availability within the body and production of erythropoietin can assist in anemic CKD patients in achieving recommended levels of hemoglobin. Acknowledgement of the potential side effects associated with the medications selected to treat anemia can help in avoiding additional injury to the patient and thus reduce healthcare expenditure. A limitation of this review is that the search was performed within a single database. Conclusions: Health care providers can play an active role in detecting anemia early and optimizing available treatment options. Future research on the effects of erythropoiesis-stimulating agents (ESA) on patients before they need dialysis, and a cost analysis between epoetin and darbepoetin alpha, would be beneficial.

AB - Objective: The purpose of this paper is to provide an overview of the current therapeutic options afforded to anemic chronic kidney disease (CKD) patients and the costs of these interventions. Methodology: Literature search of articles within Ovid MEDLINE between 1996 and 2007 that pertained to the treatment of anemia in chronic kidney disease patients. Results: Early detection and treatment of anemia associated with CKD has proven to provide positive cognitive and physical effects. Treatment options that increase iron storage and availability within the body and production of erythropoietin can assist in anemic CKD patients in achieving recommended levels of hemoglobin. Acknowledgement of the potential side effects associated with the medications selected to treat anemia can help in avoiding additional injury to the patient and thus reduce healthcare expenditure. A limitation of this review is that the search was performed within a single database. Conclusions: Health care providers can play an active role in detecting anemia early and optimizing available treatment options. Future research on the effects of erythropoiesis-stimulating agents (ESA) on patients before they need dialysis, and a cost analysis between epoetin and darbepoetin alpha, would be beneficial.

KW - Anemia

KW - Health care costs

KW - Kidney diseases

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=38549100652&partnerID=8YFLogxK

U2 - 10.1185/030079908X242782

DO - 10.1185/030079908X242782

M3 - Review article

C2 - 18034919

AN - SCOPUS:38549100652

VL - 24

SP - 129

EP - 137

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 1

ER -